B cell lipid rafts regulate both peptide-dependent and peptide-independent APC-T cell interaction

Journal of Immunology

Volumn 173, Issue 3, 2004, Pages 1876-1886

  Setterblad, Niclas ^a   Bécart, Stéphane ^a   Charron, Dominique ^a,b   Mooney, Nuala ^a  

^a INSERM   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CD4 ANTIGEN; GLYCOLIPID; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; PROTEIN KINASE C;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL INTERACTION; CELL MEMBRANE; CONJUGATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME INHIBITION; IMMUNE RESPONSE; MEMBRANE DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 3242745023     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.3.1876     Document Type: Article

References (50)

1. Cambier, J. C., M. K. Newell, L. B. Justement, J. C. McGuire, K. L. Leach, and Z. Z. Chen. 1987. Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes. Nature 327:629.
2. Brick-Ghannam, C., F. L. Huang, N. Temime, and D. Charron. 1991. Protein kinase C (PKC) activation via human leukocyte antigen class II molecules: a novel regulation of PKC activity. J. Biol. Chem. 266:24169.
3. Becart, S., N. Setterblad, S. Ostrand-Rosenberg, S. J. Ono, D. Charron, and N. Mooney. 2003. Intracytoplasmic domains of MHC class II molecules are essential for lipid-raft-dependent signaling. J Cell Sci. 116:2565.
4. Rich, T., S. E. Lawler, J. M. Lord, V. M. Blancheteau, D. J. Charron, and N. A. Mooney. 1997. HLA class II-induced translocation of PKCα and PKCβII isoforms is abrogated following truncation of DRβ cytoplasmic domains. J. Immunol. 159:3792.
5. Nabavi, N., Z. Ghogawala, A. Myer, I. J. Griffith, W. F. Wade, Z. Z. Chen, D. J. McKean, and L. H. Glimcher. 1989. Antigen presentation abrogated in cells expressing truncated Ia molecules. J. Immunol. 142:1444.
6. Nabavi, N., G. J. Freeman, A. Gault, D. Godfrey, L. M. Nadler, and L. H. Glimcher. 1992. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 360:266.
7. Brown, D. A., and E. London. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol 14:111.
8. Bromley, S. K., W. R. Burack, K. G. Johnson, K. Somersalo, T. N. Sims, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 2001. The immunological synapse. Annu. Rev. Immunol. 19:375.
9. Cherukuri, A., M. Dykstra, and S. K. Pierce. 2001. Floating the raft hypothesis: lipid rafts play a role in immune cell activation. Immunity 14:657.
10. Kropshofer, H., S. Spindeldreher, T. A. Rohn, N. Platania, C. Grygar, N. Daniel, A. Wolpl, H. Langen, V. Horejsi, and A. B. Vogt. 2002. Tetraspan microdomains distinct from lipid rafts enrich select peptide- MHC class II complexes. Nat. Immunol. 3:61.
11. Setterblad, N., C. Roucard, C. Bocaccio, J. P. Abastado, D. Charron, and N. Mooney. 2003. Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells. J. Leukocyte Biol. 74:40.
12. Hiltbold, E. M., N. J. Poloso, and P. A. Roche. 2003. MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse. J. Immunol. 170:1329.
13. Setterblad, N., S. Becart, D. Charron, and N. Mooney. 2001. Signalling via MHC class II molecules modifies the composition of GEMs in APC. Scand. J. Immunol. 54:87.
14. Becart, S., K. Boniface, M. Cherrier, O. Lanvin, V. Soulard, and F. Toulza. 2003. Forefront news in immunology from France: annual meeting of the French Society of Immunologists. Eur. Cytokine Netw. 14:115.
15. Huby, R. D., R. J. Dearman, and I. Kimber. 1999. Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts. J. Biol. Chem. 274:22591.
16. Anderson, H. A., E. M. Hiltbold, and P. A. Roche. 2000. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol. 1:156.
17. Buatois, V., M. Baillet, S. Becart, N. Mooney, L. Leserman, and P. Machy. 2003. MHC class II-peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1 phenotype. J. Immunol. 171:5812.
18. Lee, K. H., A. R. Dinner, C. Tu, G. Campi, S. Raychaudhuri, R. Varma, T. N. Sims, W. R. Burack, H. Wu, J. Wang, et al. 2003. The immunological synapse balances T cell receptor signaling and degradation. Science 302:1218.
19. Grakoui, A., S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285:221.
20. Monks, C. R., B. A. Freiberg, H. Kupfer, N. Sciaky, and A. Kupfer. 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395:82.
21. Richie, L. I., P. J. Ebert, L. C. Wu, M. F. Krummel, J. J. Owen, and M. M. Davis. 2002. Imaging synapse formation during thymocyte selection: inability of CD3ζ to form a stable central accumulation during negative selection. Immunity 16:595.
22. Trautmann, A., and S. Valitutti. 2003. The diversity of immunological synapses. Curr. Opin. Immunol. 15:249.
23. St Pierre, Y., and T. H. Watts. 1991. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells. J. Immunol. 147:2875.
24. Al-Alwan, M. M., G. Rowden, T. D. Lee, and K. A. West. 2001. The dendritic cell cytoskeleton is critical for the formation of the immunological synapse. J. Immunol. 166:1452.
25. Al-Alwan, M. M., R. S. Liwski, S. M. Haeryfar, W. H. Baldridge, D. W. Hoskin, G. Rowden, and K. A. West. 2003. Cutting edge: dendritic cell actin cytoskeletal polarization during immunological synapse formation is highly antigen-dependent. J. Immunol. 171:4479.
26. Gordy, C., S. Mishra, and W. Rodgers. 2004. Visualization of antigen presentation by actin-mediated targeting of glycolipid-enriched membrane domains to the immune synapse of B cell APCs. J. Immunol. 172:2030.
27. Wulfing, C., C. Sumen, M. D. Sjaastad, L. C. Wu, M. L. Dustin, and M. M. Davis. 2002. Costimulation and endogenous MHC ligands contribute to T cell recognition. Nat. Immunol. 3:42.
28. Blank, U., B. Boitel, D. Mege, M. Ermonval, and O. Acuto. 1993. Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma. Eur. J. Immunol. 23:3057.
29. Klohe, E. P., R. Watts, M. Bahl, C. Alber, W. Y. Yu, R. Anderson, J. Silver, P. K. Gregersen, and R. W. Karr. 1988. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules. J. Immunol. 141:2158.
30. Michel, F., L. Grimaud, L. Tuosto, and O. Acuto. 1998. Fyn and ZAP-70 are required for Vav phosphorylation in T cells stimulated by antigen-presenting cells. J. Biol. Chem. 273:31932.
31. Xavier, R., T. Brennan, Q. Li, C. McCormack, and B. Seed. 1998. Membrane compartmentation is required for efficient T cell activation. Immunity 8:723.
32. Krawczyk, C., A. Oliveira-dos-Santos, T. Sasaki, E. Griffiths, P. S. Ohashi, S. Snapper, F. Alt, and J. M. Penninger. 2002. Vav1 controls integrin clustering and MHC/peptide-specific cell adhesion to antigen-presenting cells. Immunity 16:331.
33. Bertho, N., V. M. Blancheteau, N. Setterblad, B. Laupeze, J. M. Lord, B. Drenou, L. Amiot, D. J. Charron, R. Fauchet, and N. Mooney. 2002. MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-δ isoenzyme. Int. Immunol. 14:935.
34. Harder, T., and K. Simons. 1997. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr. Opin. Cell Biol. 9:534.
35. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature 387:569.
36. Schade, A. E., and A. D. Levine. 2002. Lipid raft heterogeneity in human peripheral blood T lymphoblasts: a mechanism for regulating the initiation of TCR signal transduction. J. Immunol. 168:2233.
37. Marwali, M. R., J. Rey-Ladino, L. Dreolini, D. Shaw, and F. Takei. 2003. Membrane cholesterol regulates LFA-1 function and lipid raft heterogeneity. Blood 102:215.
38. Stulnig, T. M., J. Huber, N. Leitinger, E. M. Imre, P. Angelisova, P. Nowotny, and W. Waldhausl. 2001. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J. Biol. Chem. 276:37335.
39. Zeyda, M., G. Staffler, V. Horejsi, W. Waldhausl, and T. M. Stulnig. 2002. LAT displacement from lipid rafts as a molecular mechanism for the inhibition of T cell signaling by polyunsaturated fatty adds. J. Biol. Chem. 277:28418.
40. Rajendran, L., M. Masilamani, S. Solomon, R. Tikkanen, C. A. Stuermer, H. Plattner, and H. Illges. 2003. Asymmetric localization of flotillins/reggies in preassembled platforms confers inherent polarity to hematopoietic cells. Proc. Natl. Acad. Sci. USA 100:8241.
41. Sproul, T. W., S. Malapati, J. Kim, and S. K. Pierce. 2000. Cutting edge: B cell antigen receptor signaling occurs outside lipid rafts in immature B cells. J. Immunol. 165:6020.
42. Saeki, K., Y. Miura, D. Aki, T. Kurosaki, and A. Yoshimura. 2003. The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction. EMBO J. 22:3015.
43. Tseng, S. Y., and M. L. Dustin. 2002. T-cell activation: a multidimensional signaling network. Curr. Opin. Cell Biol. 14:575.
44. Sanui, T., A. Inayoshi, M. Noda, E. Iwata, M. Oike, T. Sasazuki, and Y. Fukui. 2003. DOCK2 is essential for antigen-induced translocation of TCR and lipid rafts, but not PKC-theta and LFA-1, in T cells. Immunity 19:119.
45. Faroudi, M., R. Zaru, P. Faulet, S. Muller, and S. Valitutti. 2003. Cutting edge: T lymphocyte activation by repeated immunological synapse formation and intermittent signaling. J. Immunol. 171:1128.
46. Barois, N., F. Forquet, and J. Davoust. 1998. Actin microfilaments control the MHC class II antigen presentation pathway in B cells. J. Cell Sci. 111:1791.
47. Al-Alwan, M. M., G. Rowden, T. D. Lee, and K. A. West. 2001. Fascin is involved in the antigen presentation activity of mature dendritic cells. J. Immunol. 166:338.
48. Stuve, O., S. Youssef, L. Steinman, and S. S. Zamvil. 2003. Statins as potential therapeutic agents in neuroinflammatory disorders. Curr. Opin. Neurol. 16:393.
49. Mach, F. 2003. Statins as novel immunomodulators: from cell to potential clinical benefit. Thromb. Haemost. 90:607.
50. Yaqoob, P. 2003. Fatty acids as gatekeeper of immune cell regulation. Trends Immunol. 24:639.